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Available online 11 October 2011Abstract In cartilaginous tissues, perichondrium cambium layer may be the source of new cartilage. Human nasal septal
perichondrium is considered to be a homogeneous structure in which some authors do not recognize the perichondrium internal
zone or the cambium layer as a layer distinct from adjacent cartilage surface. In the present study, we isolated a chondrogenic
cell population from human nasal septal cartilage surface zone. Nasoseptal chondrogenic cells were positive for surface
markers described for mesenchymal stem cells, with exception of CD146, a perivascular cell marker, which is consistent
with their avascular niche in cartilage. Although only Sox-9 was constitutively expressed, they also revealed osteogenic and
chondrogenic, but not adipogenic, potentials in vitro, suggesting a more restricted lineage potential compared to mesenchy-
mal stem cells. Interestingly, even in absence of chondrogenic growth factors in the pellet culture system, nasoseptal chondro-
genic cells had a capacity to synthesize sulfated glycosaminoglycans, large amounts of collagen type II and to a lesser extent
collagen type I. The spontaneous chondrogenic potential of this population of cells indicates that they may be a possible source
for cartilage tissue engineering. Besides, the pellet culture system using nasoseptal chondrogenic cells may also be a model for
studies of chondrogenesis.
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Cartilaginous tissue lacks an intrinsic regeneration capacity.
The tissue engineering and cell-based approaches can be thus
excellent alternatives to treat cartilage lesions (Ahmed and
Hincke, 2010). Choosing the appropriate cell type for these
therapies is a critical step. Chondrocytes are highly specialized
cells responsible for the production of cartilage extracellular
matrix (Huang, 1977), but articular chondrocytes are consid-
ered difficult to culture, have low proliferation capacity and
may dedifferentiate in monolayer cultures, losing their chon-
drogenic phenotype (Kuo et al., 2006). In addition to articular
cartilage, there are other sources of chondrocytes, such as ear
(Malicev et al., 2009) and nasal septum, with some advantages
as compared to articular chondrocytes, since they are easy to
harvest with low iatrogenic morbidity (Chia et al., 2004).
Perichondrium surrounds all mammalian cartilage tissues,
with exception of fibrocartilage and articular cartilage, where
the synovial fluid is present. Despite not having a perichondri-
um, articular cartilage contains a progenitor/stem cell popula-
tion on its surface zone (Archer et al., 1990; Dowthwaite et al.,
2004). In other cartilaginous tissues, perichondrium cambium
layer seems to be the source of new cartilage (Upton et al.,
1981) where chondroprogenitor cells dwell (Engkvist et al.,
1979). However, some authors do not recognize the perichon-
drium internal zone or cambium layer as a separate layer
from the adjacent cartilage (Bairati et al., 1996). In particular,
human nasal septal perichondrium is considered to be a homo-
geneous structure without clearly distinguishable zones (Bleys
et al., 2007), and the border between cartilage and perichon-
drium is not very clear (Bairati et al., 1996).
The aim of the present study was to isolate and charac-
terize a chondrogenic cell population from human nasal
septal cartilage surface zone, a niche similar to the articular
cartilage progenitor cell niche, pointing them as a possible
source for cartilage tissue engineering approaches.
Results and discussion
Nasoseptal chondrogenic cells dwell in surface
region of human nasoseptal cartilage
Before enzymatic digestion with collagenase IA, nasoseptal
cartilage samples exhibited two distinguishable zones: theFigure 1 Effect of enzymatic digestion on human nasoseptal cart
after (C) enzymatic digestion with collagenase type IA. Safranin O (
lagen type I (B) (in red) was detected using immunofluorescence p
and inner zones are indicated. Bar size, 50 μm.superficial and inner zones. The superficial zone showed
low affinity with Safranin O and elongated fibroblast-like
cells positioned with their long axes parallel to the cartilage
surface. The inner zone was stained with Safranin O and cells
showed a more rounded morphology organized in randomly
distributed isogenic groups (Fig. 1A). Collagen type I was
mainly detected on the surface zone (Fig. 1B). After the en-
zymatic digestion procedure, the superficial layer could no
longer be observed (Fig. 1C).
Due to the abundance of collagen type I in nasal septal
perichondrium and the difficulty to define its transition to
cartilage (Bleys et al., 2007), we suggest that the superficial
zone of the cartilage samples may correspond to perichon-
drium cambium layer. Van Osch et al. showed that ear peri-
chondrium cells had chondrogenic potential superior to nasal
perichondrium cells, but also suggested that the perichon-
drium cambium layer may have remained attached to the
septum cartilage during the nasal perichondrium harvesting,
leading to low chondrogenic capacity of the isolated tissue
(Van Osch et al., 2000). Even though we have harvested car-
tilage samples without perichondrium, it seems that a simi-
lar event occurred in our work, i.e., the perichondrium
cambium layer remained attached to the septum cartilage
during the sample harvesting.Characterization of nasoseptal chondrogenic cells
after in vitro expansion
The population of nasoseptal chondrogenic cells was positive
for CD105, CD73 and CD44 (Fig. 2A–C), surface markers de-
scribed for mesenchymal stem cells populations of different
origins (Dominici et al., 2006). A perivascular niche has been
suggested for mesenchymal stem cells in various tissues (Da
Silva Meirelles et al., 2008; Crisan et al., 2008), but as
expected, nasoseptal chondrogenic cells, that dwell in avas-
cular niche, were negative for CD146 (Fig. 2D), a perivascu-
lar cell marker first described in bone marrow samples
(Sacchetti et al., 2007). In addition, CD44, a hyaluronan re-
ceptor that organizes the pericellular matrix, was highly
expressed (Fig. 2C) and its expression is concomitant with
the reduction of intercellular spaces at early sites of future
cartilage formation (Rousche and Knudson, 2002).
On monolayer culture and in the absence of inducing
media, nasoseptal chondrogenic cells were positive only forilage samples. Images of histological sections before (A, B) and
A, C). Asterisk indicates superficial zone. Bar size, 100 μm. Col-
rotocols. Nuclei stained by Sytox green (in green). Superficial
Figure 2 Molecular characterization of nasoseptal chondrogenic cells. Flow cytometry analysis of cells harvested after third pas-
sage (A–D). The population of cells was positive for mesenchymal markers CD105 (A), CD73 (B), CD44 (C), except for CD146 (D).
Gray solid histograms represent negative controls (isotype controls). Reverse-transcriptase PCR (E–L). Amplified products of chondro-
genic cells (E, G, I, K) and of mesenchymal cells from adipose tissue (F, H, J, L), used as positive control. Chondrogenic cells are pos-
itive for SOX-9 (E) and negative for CBFA-1 (G) and PPARγ2 (I). Constitutive expression of GAPDH (K, L) as control for RT-PCR reaction.
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negative for the osteogenic master gene (CBFA-1)
(Fig. 2G), nasoseptal chondrogenic cells could deposit con-
siderable amounts of extracellular calcium under osteogenic
inducing medium (Fig. 3B). It is possible that CBFA-1 expres-
sion had been modulated during differentiation. The mecha-
nisms involved in this process should be better understood.
On the other hand, absence of the adipogenic master gene
(PPAR-γ2) (Fig. 2I) was correlated to the inability of naso-
septal chondrogenic cells to differentiate into adipocytes.
Although these cells changed their morphology to a more
rounded shape under adipogenic induction, no cytoplasmic
lipid droplets were accumulated (Fig. 3D).
The surface markers and gene expression profile, but also
the inability of multilineage differentiation in vitro mayindicate nasoseptal chondrogenic cells as a population
committed to the condrogenic lineage, while mesenchymal
stem cells from different sources have more differentiation
plasticity.Pellet culture generated a three-dimension
structure that resembled a cartilaginous tissue
In monolayer culture, cells isolated from superficial zone
showed a fibroblastoid morphology in vitro, reaching conflu-
ence in approximately 10 days after isolation (Fig. 4A). When
these cells were maintained in high cellular density pellet
culture, a 3D system, even in the absence of chondrogenic
growth factors, they switched from a fibroblastoid to an
Figure 3 Nasoseptal chondrogenic cells differentiation potential to osteogenic and adipogenic lineages. Monolayers of cells main-
tained under osteogenic (B) or adipogenic (D) inducting media for 21 days. After this period, they were fixed and stained with Alizarin
Red to reveal calcium deposits, and with Oil Red O to detect lipid droplets. Control media (A, C); inducing media (B, D). Bar size,
50 μm.
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cans, as shown by a strong Safranin O staining (Fig. 4B). Elon-
gated cells, present on the pellet surface, can also be
detected on agarose clusters surface prepared with surface
articular chondrocytes, but not on agarose clusters prepared
with deep zone articular chondrocytes (Archer et al., 1990).
Collagen type I was less detected throughout the pellet
(Fig. 4C) while collagen type II was clearly present
(Fig. 4D). For a successful chondrogenic differentiation,
i.e. with high levels of collagen type II and sulfated glycos-
aminoglycans, bone marrow-derived mesenchymal stem
cells (Johnstone et al., 1998), adipose-derived mesenchymal
stem cells (Estes et al., 2010) and dedifferentiated articular
chondrocytes (Barbero et al., 2003) must be culture in a 3D
system with chondrogenic growth factors as TGF-βs and
BMPs. For nasoseptal chondrogenic cells grown up to the
third passage, the addition of such growth factors was not
necessary for a successful chondrogenic differentiation,
which highlights its chondrogenic commitment.
This chondrogenic commitment, together with inability
of multilineage differentiation, could be explained, in part,
by nasoseptal chondrogenic cells niche, which may corre-
spond to perichondrium cambium layer, and surface markers
and gene expression profile, as high CD44 expression but not
CD146, and expression of only the chondrogenic master gene
mRNA, as already discussed. More specifically, the absence
of PPAR-γ2 mRNA expression on nasoseptal chondrogenic
cells may have strong implications. Some reports on litera-
ture suggest a mutually antagonistic relationship between
reduced PPAR-γ expression and increased TGF-β signaling
in a lung model of development (Nicola et al., 2011) and fi-
brosis (Kulkarni et al., 2011). Chondrocytes seem to respond
in a similar way to high levels of PPAR-α, β/δ or γ, whereas
PPAR agonists reduce the stimulating effect of TGF-β1 onextracellular matrix components synthesis (Poleni et al.,
2007; Poleni et al., 2010). Exogenous TGF-β is not required
for cartilage matrix synthesis on nasoseptal chondrogenic
cells perhaps because this signaling pathway is not ham-
pered by PPARs.
In pellet culture system nasoseptal chondrogenic cells
revealed a typical pattern of organelles described on superfi-
cial chondrocytes, as a prominent Golgi complex and enlarged
rough endoplasmic reticulum cistern, which distinguish them
from other perichondrium cells (Bairati et al., 1996). Small
lipid droplets and large amounts of glycogen in their cytoplasm
can also be observed (Fig. 4E, F). The pattern of organelles
observed suggests that this population of cells belongs to the
chondrogenic lineage.
Much of our current understanding concerning the molecu-
larmechanisms of chondrogenesis has been delineated in vitro
utilizing high cellular density culture systems. Nasoseptal
chondrogenic cells under pellet culture system had an extra-
cellular matrix content very similar to cartilage, being a
potential model for studying chondrogenesis. Besides, the
chondrogenic commitment observed in nasoseptal chondro-
genic cells may be very useful for cartilage engineering,
since it has been reported that chondrogenic differentiation
of mesesenchymal stem cells usually results in a significant
proportion of fibrocartilage (Steck et al., 2005).Material and methods
Human cartilage sampling
Cartilage fragments from nasoseptal were obtained from do-
nors (n=12) from 25 to 40 years old that underwent esthetic
surgery procedures. The study has been approved by the
Figure 4 Spontaneous differentiation potential into the chondrogenic lineage. Nasoseptal chondrogenic cells in monolayer culture
revealed fibroblastoid morphology (A). Phase contrast microscopy — bar size, 100 μm. Pellet culture maintained under control media
(no chondrogenic induction) for 28 days. After this period, they were fixed and stained with Safranin O (B) to reveal sulfated glycos-
aminoglycans. Bar size, 60 μm. Immunofluorescence protocols for collagen type I (C) and type II (D) (in red) were also performed. Nu-
clei stained by Sytox green (in green). (C, D) Bar size, 25 μm. Insets (lower power image) — bar size, 50 μm. Pellet culture maintained
under control media for 15 days, observed by transmission electron microscopy (E, F). Arrowheads in E represent small cytoplasmic
lipid droplets and prominent Golgi complexes, in F an enlarged rough endoplasmic reticulum cistern and large amounts of glycogen.
(E, F) Bar size, 2 μm and 1 μm, respectively.
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University Hospital, Federal University of Rio de Janeiro,
Brazil.Isolation and culture of cells
Cartilage fragments wereminced into small pieces and rapidly
incubated with collagenase IA (Sigma). Cartilage samples
were collected before and after digestion for histological
evaluation.
Cells were harvested by centrifugation and plated in
tissue culture flasks with alpha-minimum essential medium
(alpha-MEM, Sigma Chemical Co) containing 10% fetal bovine
serum (FBS, LGC), 100 U/mL penicillin, and 100 μg/mL
streptomycin. Cultures were maintained at 37 °C in ahumid atmosphere with 5% CO2, and the medium was chan-
ged every 3–5 days until cell monolayer reached confluence.
At confluence, cells were harvested with 0.78 mM EDTA
(Gibco) and 0.125% trypsin (Gibco) and re-seeded at a densi-
ty of 104 cells/cm2. Dissociation with trypsin followed by re-
seeding for cell expansion was denominated “passage”.
Pellet cultures were performed as described previously
(Johnstone et al., 1998; Baptista et al., 2009a), with cells
from up to the third passage. For transmission electron
microscopy analysis, pellet cultures (n=3) were fixed at
15 days in 2.5% glutaraldehyde buffered with 0.1 M sodium
cacodylate and post fixed with 1% OsO4 (all from Electron
Microscopy Sciences) in the same buffer. Samples were
dehydrated in graded acetone (Merck) and embedded in
the Epon resin (Electron Microscopy Sciences). Sections
of 70 nm were obtained on ultramicrotome (EM UC6) and
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Tecnai Spirit 12).
Flow cytometry analysis
Cells were monitored for surface marker expression at the
first passage (n=4) using flow cytometry. Harvested cells
were washed with phosphate-buffered-saline containing 3%
bovine serum albumin (PBS-BSA 3%) and incubated for
30 min at 4 °C with mouse monoclonal antibodies conjugated
with fluorescent dies: CD44-phycoerythrin (PE), CD73-PE,
CD146-PE (all from BD Biosciences) and CD105-PE (R&D
Systems). Subsequently, cells were washed with PBS-BSA 3%.
Fifty thousand events were acquired per antibody set, on
FACSCanto flow cytometer equipped with FACS Diva Software
4.3.
RT-PCR analysis
Cells were monitored for mRNA gene expression at the sec-
ond passage (n=3), as described previously (Baptista et al.,
2009b). Mesenchymal stem cells from adipose tissue were
used as positive controls. Reaction settings had an initial de-
naturation step of 5 min at 95 °C, followed by 36 cycles of
1 min at 95 °C, 1 min at annealing temperature for each
primer used (Supplemental — Table 1), and 1 min at 72 °C.
Finally, samples were maintained for 5 min at 72 °C. Reac-
tion products were resolved by electrophoresis on a 1.2%
agarose (Invitrogen) gel and incubated with GelRed (Bio-
tium) for visualization under UV light.
Cell differentiation assays
Osteogenic and adipogenic potential was investigated in
vitro using the appropriate inducting media with cells from
up to the third passage (n=3, for each assay), as described
previously (Baptista et al., 2009a). Following lineage differ-
entiation induction, cells were fixed in 10% formaldehyde
(Vetec) for 60 min. Adipogenic differentiation was assessed
using Oil Red O staining (Sigma) as an indicator of intracellu-
lar lipid accumulation. Osteogenic differentiation was
assessed using alizarin red staining (Sigma) as an indicator
of extracellular calcium deposition (Baptista et al., 2009b).
Chondrogenic potential was monitored in pellet cultures
under absence of growth factors commonly used to induce
chondrocyte phenotype. After 28 days, histological and
immunofluorescence protocols were performed in these
cultures.
Histological evaluation
For histological preparations, pellet and cartilage samples
(n=4, each) were fixed in 10% formaldehyde. Samples were
dehydrated in graded ethanol, cleared in xylol, and embed-
ded in paraffin (all from Vetec). Cartilage samples were dec-
alcified with a solution of formaldehyde/formic acid prior to
dehydration process. Sections of 5 μm of both samples were
obtained on American Optical Microtome. Histological sec-
tions were stained with Safranin O counterstained by FastGreen (all from Sigma) to assess glycosaminoglycan content,
as described previously (Grogan et al., 2006). Sections were
examined under an optical microscope (Leica DMI 6000 B)
equipped with Leica DFC 500 digital camera.
Immunofluorescence analysis
For frozen sections, pellet and cartilage samples (n=4, each)
were fixed in 4% paraformaldehyde (Vetec) for subsequent
embedding in OCT compound (Sakura Finetek). Sections of
10 μm were obtained on Leica C1850 cryostat and mounted
on microscope slides. Antigen unmasking was done by treat-
ment with hyaluronidase (4800 U/ml — Sigma). Unspecific
binding of immunoglobulins was blocked with 5% PBS/BSA,
5% goat serum and 0.5% Triton for 1.5 h. Sections were incu-
bated overnight at 4 °C with primary antibodies (1:50) for
type I collagen or type II collagen (both from Santa Cruz Bio-
tech). Secondary antibody staining was performed using
Alexa fluor 594 conjugate anti-mouse IgG for 1 h at room
temperature. Nuclei were stained with Sytox green —
1:500, (Invitrogen — Molecular Probes). Slides were mounted
in a commercial Vectashield® Mounting Medium (Vector Lab)
and examined under a confocal fluorescence microscope
(Leica TCS SP5).
Conclusions
There are various applications for cell-based therapies in
cartilage repair. For knee cartilage lesion treatment, autol-
ogous chondrocyte transplantation has become the principal
cell-based approach. The first human autologous chondro-
cyte transplantation was done by a Swedish group in 1994
(Brittberg et al., 1994). Although this has granted clinical
benefits including pain relief with function improvement
(Recht et al., 2003; Ferruzzi et al., 2008), it still remains un-
satisfactory, mainly because of the morbidity in the donor
site caused by the harvesting of the articular cartilage
(Hunziker, 2002). It has also been reported that the repair
tissue still contains a considerable proportion of fibrocarti-
lage (McNickle et al., 2009).
In maxillofacial surgery, the repair and augmentation of
craniofacial structures or repair of nose deformities is a
challenge for surgeons. The current clinical practice is to
treat these deformities with the combination of surgery
and the use of autologous tissues. However, grafting autolo-
gous tissue is associated with difficulty to obtain a sufficient
amount of tissue (Yanaga et al., 2006).
Some authors indicate perichondrium as a good cell
sources for cartilage repair (Van Osch et al., 2000; Togo et
al., 2006), while others do not, claiming inconsistent repro-
ducibility and yield rate of neocartilage (Shieh et al., 2004).
Also, the repair tissue formed by these perichondrium cells
in vivo is different from the native one (Dounchis et al.,
2000) and unstable after long periods (Ostrander et al.,
2001). Apart from this discussion, it seems that no study
worked specifically with cells of the cartilage superficial
zone or perichondrium cambium layer, suggested to be the
source of new cartilage (Upton et al., 1981).
Mesenchymal progenitor cells have been reported in nor-
mal and osteoarthritic articular cartilage (Alsalameh et al.,
2004). The surface of articular cartilage contains pluripotent
298 R.J.F.C. Amaral et al.progenitor cells (Dowthwaite et al., 2004). Although naso-
septal chondrogenic cells were not reported to present
such plasticity, they also occupy a surface niche on cartilag-
inous tissue, belonging to chondrogenic lineage.
Further studies are necessary to prove that nasoseptal
chondrogenic cells can efficiently generate cartilaginous
tissue in vivo and to compare its chondrogenic potential
against other progenitor cell types. However, engineering
articular cartilage with biomimetic scaffolds is being pointed
as a major strategy for success of cartilage engineering in
the future (Klein et al., 2009). Therefore, combination of
different cell types is an advantage, and nasoseptal chondro-
genic cells may occupy the superficial niche in a construct.
Finally, nasoseptal chondrogenic cells may not only be used
for clinical implants, but also as a model for studying
chondrogenesis.
Supplementary materials related to this article can be
found online at doi:10.1016/j.scr.2011.09.006.
Acknowledgments
To the Instituto Nacional de Metrologia Normalização e Qua-
lidade Industrial (Inmetro) for the transmission electron mi-
croscope (FEI-Tecnai Spirit 12) and the confocal
fluorescence microscope (Leica TCS SP5). Also to Dr. Fer-
nanda Von-Held for providing cartilage samples.
References
Ahmed, T.A., Hincke, M.T., 2010. Strategies for articular cartilage
lesion repair and functional restoration. Tissue Eng. Part B Rev.
16 (3), 305–329.
Alsalameh, S., Amin, R., Gemba, T., Lotz, M., 2004. Identification of
mesenchymal progenitor cells in normal and osteoarthritic
human articular cartilage. Arthritis Rheum. 50 (5), 1522–1532.
Archer, C.W., McDowell, J., Bayliss, M.T., Stephens, M.D., Bentley,
G., 1990. Phenotypic modulation in sub-populations of human
articular chondrocytes in vitro. J. Cell Sci. 97 (Pt 2), 361–371.
Bairati, A., Comazzi, M., Gioria, M., 1996. A comparative study of
perichondrial tissue in mammalian cartilages. Tissue Cell 28 (4),
455–468.
Baptista, L.S., do Amaral, R.J., Carias, R.B., Aniceto, M., Claudio-
da-Silva, C., Borojevic, R., 2009a. An alternative method for
the isolation of mesenchymal stromal cells derived from lipoaspi-
rate samples. Cytotherapy 11 (6), 706–715.
Baptista, L.S., da Silva, K.R., da Pedrosa, C.S., Claudio-da-Silva, C.,
Carneiro, J.R., Aniceto, M., de Mello-Coelho, V., Takiya, C.M.,
Rossi, M.I., Borojevic, R., 2009b. Adipose tissue of control and
ex-obese patients exhibit differences in blood vessel content
and resident mesenchymal stem cell population. Obes. Surg.
19 (9), 1304–1312.
Barbero, A., Ploegert, S., Heberer, M., Martin, I., 2003. Plasticity of
clonal populations of dedifferentiated adult human articular
chondrocytes. Arthritis Rheum. 48 (5), 1315–1325.
Bleys, R.L., Popko, M., De Groot, J.W., Huizing, E.H., 2007. Histo-
logical structure of the nasal cartilages and their perichondrial
envelope. II. The perichondrial envelope of the septal and lobu-
lar cartilage. Rhinology 45 (2), 153–157.
Brittberg, M., Lindahl, A., Nilsson, A., Ohlsson, C., Isaksson, O.,
Peterson, L., 1994. Treatment of deep cartilage defects in the
knee with autologous chondrocyte transplantation. N. Engl. J.
Med. 331 (14), 889–895.
Chia, S.H., Schumacher, B.L., Klein, T.J., Thonar, E.J., Masuda, K.,
Sah, R.L., Watson, D., 2004. Tissue-engineered human nasalseptal cartilage using the alginate-recovered-chondrocyte meth-
od. Laryngoscope 114 (1), 38–45.
Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park,
T.S., Andriolo, G., Sun, B., Zheng, B., Zhang, L., Norotte, C.,
Teng, P.N., Traas, J., Schugar, R., Deasy, B.M., Badylak, S.,
Buhring, H.J., Giacobino, J.P., Lazzari, L., Huard, J., Péault,
B., 2008. A perivascular origin for mesenchymal stem cells in
multiple human organs. Cell Stem Cell 3 (3), 301–313.
Da Silva Meirelles, L., Caplan, A.I., Nardi, N.B., 2008. In search of
the in vivo identity of mesenchymal stem cells. Stem Cells 26 (9),
2287–2299.
Dominici, M., Le Blanc, K., Mueller, I., Slaper-Cortenbach, I.,
Marini, F., Krause, D., Deans, R., Keating, A., Prockop, D.J.,
Horwitz, E., 2006. Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for Cellular
Therapy position statement. Cytotherapy 8 (4), 315–317.
Dounchis, J.S., Coutts, R.D., Amie, l.D., 2000. Cartilage repair with
autogenic perichondrium cell/polylactic acid grafts: a two-year
study in rabbits. J. Orthop. Res. 18 (3), 512–515.
Dowthwaite, G.P., Bishop, J.C., Redman, S.N., Khan, I.M., Rooney,
P., Evans, D.J., Haughton, L., Bayram, Z., Boyer, S., Thomson,
B., Wolfe, M.S., Archer, C.W., 2004. The surface of articular car-
tilage contains a progenitor cell population. J. Cell Sci. 117 (Pt 6),
889–897.
Engkvist, O., Skoog, V., Pastacaldi, P., Yormuk, E., Juhlin, R., 1979.
The cartilaginous potential of the perichondrium in rabbit ear
and rib. A comparative study in vivo and in vitro. Scand. J.
Plast. Reconstr. Surg. 13 (2), 275–280.
Estes, B.T., Diekman, B.O., Gimble, J.M., Guilak, F., 2010. Isolation
of adipose-derived stem cells and their induction to a chondro-
genic phenotype. Nat. Protoc. 5 (7), 1294–1311.
Ferruzzi, A., Buda, R., Faldini, C., Vannini, F., Di Caprio, F.,
Luciani, D., Giannini, S., 2008. Autologous chondrocyte implan-
tation in the knee joint: open compared with arthroscopic tech-
nique. Comparison at a minimum follow-up of five years. J. Bone
Joint Surg. Am. 90 (4), 90–101.
Grogan, S.P., Barbero, A., Winkelmann, V., Rieser, F., Fitzsimmons,
J.S., O'Driscoll, S., Martin, I., Mainil-Varlet, P., 2006. Visual his-
tological grading system for the evaluation of in vitro-generated
neocartilage. Tissue Eng. 12 (8), 2141–2149.
Huang, D., 1977. Extracellular matrix–cell interactions and chon-
drogenesis. Clin. Orthop. Relat. Res. 123, 169–176.
Hunziker, E.B., 2002. Articular cartilage repair: basic science and
clinical progress. A review of the current status and prospects.
Osteoarthr. Cartil. 10 (6), 432–463.
Johnstone, B., Hering, T.M., Caplan, A.I., Goldberg, V.M., Yoo,
J.U., 1998. In vitro chondrogenesis of bone marrow-derived
mesenchymal progenitor cells. Exp. Cell Res. 238 (1), 265–272.
Klein, T.J., Malda, J., Sah, R.L., Hutmacher, D.W., 2009. Tissue
engineering of articular cartilage with biomimetic zones. Tissue
Eng. Part B Rev. 15 (2), 143–157.
Kulkarni, A.A., Thatcher, T.H., Olsen, K.C., Maggirwar, S.B.,
Phipps, R.P., Sime, P.J., 2011. PPAR-γ ligands repress TGFβ-
induced myofibroblast differentiation by targeting the PI3K/Akt
pathway: implications for therapy of fibrosis. PLoS One 6 (1)
e:15909.
Kuo, C.K., Li, W.J., Mauck, R.L., Tuan, R.S., 2006. Cartilage tissue en-
gineering: its potential and uses. Curr. Opin. Rheumatol. 18 (1),
64–73.
Malicev, E., Kregar-Velikonja, N., Barlic, A., Alibegović, A., Drobnic,
M., 2009. Comparison of articular and auricular cartilage as a cell
source for the autologous chondrocyte implantation. J. Orthop.
Res. 27 (7), 943–948.
McNickle, A.G., L'Heureux, D.R., Yanke, A.B., Cole, B.J., 2009.
Outcomes of autologous chondrocyte implantation in a diverse
patient population. Am. J. Sports Med. 37 (7), 1344–1350.
Nicola, T., Ambalavanan, N., Zhang, W., James, M.L., Rehan, V.K.,
Halloran, B.A., Olave, N., Bulger, A., Oparil, S., Chen, Y.F.,
299Isolation of human nasoseptal chondrogenic cells: A promise for cartilage engineering2011. Hypoxia-induced inhibition of lung development is attenu-
ated by the peroxisome proliferator-activated receptor-
{gamma} agonist rosiglitazone. Am. J. Physiol. Lung Cell Mol.
Physiol. [Epub ahead of print].
Ostrander, R.V., Goomer, R.S., Tontz,W.L., Khatod, M., Harwood, F.L.,
Maris, T.M., Amiel, D., 2001. Donor cell fate in tissue engineering for
articular cartilage repair. Clin. Orthop. Relat. Res. 389, 228–237.
Poleni, P.E., Bianchi, A., Etienne, S., Koufany, M., Sebillaud, S.,
Netter, P., Terlain, B., Jouzeau, J.Y., 2007. Agonists of peroxi-
some proliferators-activated receptors (PPAR) alpha, beta/
delta or gamma reduce transforming growth factor (TGF)-beta-
induced proteoglycans' production in chondrocytes. Osteoarthr.
Cartil. 15 (5), 493–505.
Poleni, P.E., Etienne, S., Velot, E., Netter, P., Bianchi, A., 2010. Acti-
vation of PPARs α, β/δ, and γ impairs TGF-β1-induced collagens'
production and modulates the TIMP-1/MMPs balance in three-
dimensional cultured chondrocytes. PPAR Res. 2010, 635912.
Recht, M., White, L.M., Winalski, C.S., Miniaci, A., Minas, T.,
Parker, R.D., 2003. MR imaging of cartilage repair procedures.
Skeletal Radiol. 32 (4), 185–200.
Rousche, K.T., Knudson, C.B., 2002. Temporal expression of CD44
during embryonic chick limb development and modulation of its
expression with retinoic acid. Matrix Biol. 21 (1), 53–62.
Sacchetti, B., Funari, A., Michienzi, S., Di Cesare, S., Piersanti, S.,
Saggio, I., Tagliafico, E., Ferrari, S., Robey, P.G., Riminucci,M., Bianco, P., 2007. Self-renewing osteoprogenitors in bone
marrow sinusoids can organize a hematopoietic microenviron-
ment. Cell 131 (2), 324–336.
Shieh, S.J., Terada, S., Vacanti, J.P., 2004. Tissue engineering
auricular reconstruction: in vitro and in vivo studies. Biomate-
rials 25 (9), 1545–1557.
Steck, E., Bertram, H., Abel, R., Chen, B., Winter, A., Richter, W.,
2005. Induction of intervertebral disc-like cells from adult
mesenchymal stem cells. Stem Cells 23 (3), 403–411.
Togo, T., Utani, A., Naitoh, M., Ohta, M., Tsuji, Y., Morikawa, N.,
Nakamura, M., Suzuki, S., 2006. Identification of cartilage
progenitor cells in the adult ear perichondrium: utilization for
cartilage reconstruction. Lab. Invest. 86 (5), 445–457.
Upton, J., Sohn, S.A., Glowacki, J., 1981. Neocartilage derived from
transplanted perichondrium: what is it? Plast. Reconstr. Surg.
68 (2), 166–174.
Van Osch, G.J., Van Der Veen, S.W., Burger, E.H., Verwoerd-Verhoef,
H.L., 2000. Chondrogenic potential of in vitro multiplied rabbit
perichondrium cells cultured in alginate beads in defined medium.
Tissue Eng. 6 (4), 321–330.
Yanaga, H., Yanaga, K., Imai, K., Koga, M., Soejima, C., Ohmori, K.,
2006. Clinical application of cultured autologous human auricu-
lar chondrocytes with autologous serum for craniofacial or
nasal augmentation and repair. Plast. Reconstr. Surg. 117 (6),
2019–2030.
